Description
R&D CELL RESEARCH
First action · last action
2020-01-13 · 2021-03-10
Transactions
2
First transaction's obligation
$225,000
Base + all options value (sum of deltas)
$225,636
Extent competed
NOT COMPETED
Other than full & open authority
UNIQUE SOURCE (FAR 6.302-1(B)(1))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-01-13+$225,000= $225,000
- Mod P000022021-03-10+$636= $225,636
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-01-13 | +$225,000 | $225,000 | R&D CELL RESEARCH |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2021-03-10 | +$636 | $225,636 | R&D CELL RESEARCH |
Related awards · 1
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI XBBJYPDQAU19)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26123P1681 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · AN42 · HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | $30,750 | FY2023 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24620P0455_3600_-NONE-_-NONE- · retrieved 2026-09-26.